PROVOKEDmagazine: For women who are nowhere near done.

Why Are There No Screening Tests for Ovarian Cancer?

November 17, 2026
Image: Deagreez/Getty

The symptoms are easy to blame on something else, a normal Pap won’t catch it, and most women don’t find out until stage 3 or 4.

When my BFF Kristine, 59, a vibrant creative director and Pilates devotee from Seattle, began feeling “off” earlier this year, she never suspected ovarian cancer (OC). After all, last year she’d sailed through her women’s wellness checkup with a normal Pap smear result. Her GP never mentioned the possibility to her either, despite Kristine seeking care for frequent bouts of constipation and diarrhea, a newly bloated and distended stomach, chronic fatigue, and intermittent, shifting belly pain.

Which isn’t to say she didn’t battle scary thoughts. Could it be colon cancer? she texted me in May, her fear vibrating over the phone. She asked me this not only as her best friend of 35 years—we met while working entry-level jobs at the Minnesota Star Tribune, slinging back Friday night kamikaze shots and twerking to Sir Mix-A-Lot at a nightclub Prince made famous—but also as a professional health editor and writer. I srsly doubt it! I texted back. What kind of tumor pain moves around?

Her doctor tested for a urinary tract infection and ordered a colonoscopy. Both clear. It was only when Kristine listened to her own nagging intuition and asked—no, “insisted,” she said—for a CT scan in July that she learned she had three ovarian masses, plus multiple nodules inside her peritoneal lining with dysplasia found on her colon, too. Her diagnosis? Stage 3C metastatic ovarian cancer. The average estimated five-year survival rate for stage 3 overall is 41%.

The news stunned Kristine and everyone who loves her. Yet her story isn’t unique. In fact, 70%–80% of women with ovarian cancer are first diagnosed in stages 3 and 4, after it has spread beyond the pelvis.

A big reason for this? There are no reliable screening tests for OC. None. Which leaves all women vulnerable. Now consider that the median age of ovarian cancer diagnosis is 63, a time of life when many women are coming off a decade (or more) of rollercoaster, hormone-related health concerns that are too often shrugged off as part of getting older.

What’s more, “the symptoms of ovarian cancer are incredibly vague,” said Dr. Carrie L. Langstraat, a gynecologic oncologist at Mayo Clinic in Rochester, Minnesota. They include “loss of appetite due to a feeling of fullness, the bowels not working normally, and persistent abdominal pain,” she added. All of which are easy to blame on other common causes as varied as gastritis and menopause.

Kristine says her normal Pap result gave her a false sense of security. Could yours be doing the same?

A Pap Smear Only Tests for Cervical Cancer

If you’re like Kristine, me, and a zillion other women, every few years you climb onto the exam table in a paper gown, grit your teeth, and slide your feet into the stirrups with the assumption that your OB-GYN’s tour of your privates is the best way to spot internal reproductive trouble.

But a Pap only collects cells from the cervix, the narrow end of the uterus that opens into the vagina. This cell sample is checked for abnormal changes, often caused by the human papillomavirus (HPV), linked to about 99% of all cervical cancers. Your gyno will also likely press down onto the exterior of your abdomen and insert a couple of fingers inside your vagina to feel around for possible hard masses during a pelvic exam, a technique “the data show is not very effective at detecting ovarian cancer,” Dr. Langstraat noted.

And because a Pap only screens your cervix, that means your uterus, fallopian tubes, and ovaries—all located where your physician can’t inspect them without imaging tests—often remain overlooked.

Who’s at Higher Risk

Anyone with ovaries is at risk for OC. About one in 91 women will develop it in their lifetime. If you started your period before age 12, have never given birth, started menopause after age 52, or have endometriosis, your risk is higher, per the American Cancer Society.

Those odds jump for women with a family history of breast and/or ovarian cancer or who carry certain inherited genetic mutations. In fact, 10%–25% of ovarian cancers are hereditary. Women who carry an inherited harmful variant in the BRCA1 gene have a 39%–58% lifetime risk of OC, while women with a BRCA2 variant face a 13%–29% risk. Kristine’s biopsied tumor tested positive for BRCA2; testing to see if she inherited it is still in the works.

To find out if you have a genetic mutation, ask your doctor to be tested, Dr. Langstraat said, though not all insurers cover the cost. You should definitely consider testing if you have a close blood relative—a mother or a sister—who has OC or has tested positive for a troublesome gene herself, she added. If your test comes back positive, your next step is to consult with a specialist to build a personalized risk-management plan.

So There Are Screenings, Right? 

For a disease with vague symptoms and high mortality rates, you’d think there would be robust screening tests to catch OC before it spreads. Especially given that many ovarian cancers, particularly high-grade serous cancers, are thought to originate in the fallopian tubes and then spread before a mass can be detected.

The answer, shockingly, is nope, although certain blood markers may—or may not—tip off a doctor to ovarian cancer, said Dr. Roni Nitecki Wilke, an assistant professor in the Department of Gynecologic Oncology and Reproductive Medicine at MD Anderson Cancer Center in Houston. 

Take CA-125. This protein is often elevated in women with OC, yet endometriosis, uterine fibroids, and even menstruation can increase levels, too, raising false flags (not to mention existential dread). Two large clinical trials—PLCO and UKCTOCS—both revealed CA-125’s true shortcoming: flagging the protein’s presence didn’t reduce ovarian cancer deaths, which is the metric for what makes a good screening test, said Dr. Wilke.

All of which raises the question: Are women totally out of luck when it comes to early detection of OC? Dr. Langstraat noted that there are potentially game-changing innovations in the works, plus an imaging tool already widely in use that can be an important first step in catching OC.

Though not typically conducted as part of annual women’s wellness exams, transvaginal ultrasound (TVUS) can detect masses “on an ovary, an ovary with fluid around it, and ovaries with peritoneal disease,” Dr. Langstraat asserted. If it’s in the pelvis, an ultrasound will typically see it. While most masses turn out to be benign, tissue from all suspicious masses must be biopsied to diagnose cancer. If you’re having symptoms and the tests so far haven’t explained them, asking for TVUS may help you find OC earlier.

We’re All Kristine When It Comes to OC Screening

To date, Kristine, whom I talk and text every day, is through the first three of six scheduled rounds of platinum-based chemotherapy. In September, she cropped her hair close to her scalp, then bought a wig that looks like her former chic lob—she calls it “Esme”—to avoid being flagged as a sick person when she’s out. “I want to choose when and where I share my story,” she explained. “If I run into someone at the grocery store, I may not want to get into it in the toilet paper aisle.” Esme, quite literally, gives her cover.

She also emerged in October, fighting spirit intact, from an eight-hour surgery. Her ovaries, fallopian tubes, uterus, and appendix were removed, along with all visible tumors. Tumors on her peritoneal lining were debulked (a surgeon’s word for removing as much tumor as possible). While her surgeons did find spread adjacent to her colon, plus more cancer in her diaphragm, they managed to cut it all out without having to take any tissue from her liver, bowel, or lungs. Her abdominal cavity then soaked for two hours in a chemo bath (called HIPEC) before she was sewn up. She can expect at least four weeks of post-op recovery before she receives (what we both pray will be) her final three chemo infusions.

From her hospital bed, Kristine is sharing her story because, she said, “I don’t want other women caught off guard like I was.” Her message: Until science-backed, validated screenings become part of the women’s wellness exam, don’t assume a normal Pap result equates to reproductive health. And when it comes to lingering, unexplained abdominal symptoms, unapologetically self-advocate for CT or TVUS imaging just like my BFF did: Don’t ask. Insist. 

**************

Reviewed by Sonya Maynard, health and wellness fact-checker, in October 2026.

MEDICAL ADVICE DISCLAIMER

DISCLAIMER: This website does not provide medical advice. For health or wellness-related content, SFD Media LLC emphasizes that information about medicines, treatments, and therapeutic goods (including text, graphics, and images) is provided for general information only. No material on this site is intended to substitute for professional medical advice, diagnosis, or treatment. Users are advised to independently evaluate and verify the accuracy, reliability, and suitability of the information before relying on it. You should not rely on the content as a substitute for professional medical advice. Consult with a physician or other healthcare professional for any health concerns or questions you may have. SFD Media LLC is not responsible for any action taken based on the information provided on this website. The use of any information provided on this website is solely at your own risk.

Lauren Paige Kennedy has been writing and editing health content for more than 20 years. She is a founding editor or WebMD Magazine and former deputy editor of HealthCentral. Currently, she lives in New York City and Cambridge, MA. 

Leave a Comment

Your email address will not be published. Required fields are marked *

PROVOKED magazine logo
Like what you're reading? Sign up for more, free.
Life, culture, relationships, and more for women 50+